Inhibiting Matrix Metalloproteinase by Cell-Based Gene Transfer Effectively Treats Acute and Chronic Ischemic Cardiomyopathy
After a myocardial infarction (MI), an increase in the cardiac ratio of matrix metalloproteinases (MMPs) relative to their inhibitors (TIMPs) causes extracellular matrix modulation that leads to ventricular dilatation and congestive heart failure. Cell therapy can mitigate these effects. In this stu...
Main Authors: | Hai Tian M.D., Ph.D., Ming-Li Huang, Kai-Yu Liu, Zhi-Bo Jia, Lu Sun, Shu-Lin Jiang, Wei Liu, Heather Y. Mcdonald Kinkaid, Jun Wu, Ren-Ke Li M.D., Ph.D. |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2012-05-01
|
Series: | Cell Transplantation |
Online Access: | https://doi.org/10.3727/096368911X601000 |
Similar Items
-
Association of Matrix Metalloproteinase 8 Genetic Polymorphisms with Bronchial Asthma in a Japanese Population
by: Terufumi Shimoda M.D., Ph.D., et al.
Published: (2013-09-01) -
Adventitial matrix metalloproteinase production and distribution of immunoglobulin G4-related abdominal aortic aneurysms
by: Satomi Kasashima, MD, PhD, et al.
Published: (2020-01-01) -
Impact of complete revascularization in coronary artery bypass grafting for ischemic cardiomyopathyCentral MessagePerspective
by: Masaro Nakae, MD, et al.
Published: (2023-09-01) -
RhoA G17E/Vav1 Signaling Induces Cancer Invasion via Matrix Metalloproteinase-9 in Gastric Cancer
by: Satoshi Nakamura MD, et al.
Published: (2023-01-01) -
Ventricular arrhythmias following coronary artery bypass grafting for ischemic cardiomyopathy: When to insert an implanted cardioverter defibrillator?Central MessagePerspective
by: Masaro Nakae, MD, et al.
Published: (2023-03-01)